Dow Down 0.17% Nasdaq Down 0.28%

Geron Corporation (GERN)

-NasdaqGS
2.00 Down 0.16(7.41%) Sep 30, 4:00PM EDT
|After Hours : 2.00 0.00 (0.00%) Sep 30, 6:59PM EDT
Prev Close:2.16
Open:2.14
Bid:1.98 x 400
Ask:N/A
1y Target Est:4.13
Beta:2.66
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:1.98 - 2.17
52wk Range:1.31 - 7.36
Volume:3,462,181
Avg Vol (3m):2,411,190
Market Cap:313.77M
P/E (ttm):N/A
EPS (ttm):-0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNDown 7.41%313.77M
BMYDown 1.02%84.85B
GSKDown 0.69%110.42B
NVSUp 0.61%228.38B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):277.53
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.23
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-1.90

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback